Both MNCs, Local Korean Pharmas Under Korean Government Surveillance For IP Protection
This article was originally published in PharmAsia News
Executive SummarySEOUL - In its first examination into intellectual property rights related to deals among pharma companies operating in Korea, South Korea's Fair Trade Commission is now accepting complaints and opinions from 30 leading multinational companies and 18 local Korean companies
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).